Mayo Clinic teams up with Cerebras Systems to advance healthcare AI

The Mayo Clinic, a renowned non-profit medical institution based in Rochester, Minnesota, announced a strategic partnership with the Silicon Valley-based startup Cerebras Systems on Monday (15th of January, 2024). This collaboration aims to harness the power of artificial intelligence (AI) in enhancing healthcare services.

With significant presences across three major campuses in the United States and additional facilities in the United Kingdom and the United Arab Emirates, the Mayo Clinic is set to utilise cutting-edge computing chips and systems supplied by Cerebras. The collaboration will delve into the Mayo Clinic’s extensive archive of anonymised medical records and data, laying the groundwork for the development of bespoke AI models.

According to Matthew Callstrom, Mayo’s Medical Director for Strategy and Chair of the Radiology Department, these AI models are poised to revolutionise various aspects of medical record management and diagnostics. Some models are being designed to interpret and summarise extensive medical records for new patients, streamlining the patient onboarding process. Additionally, other models will focus on identifying intricate patterns in medical imagery and genome data, patterns that might elude even the most experienced medical professionals. However, Callstrom emphasised that these systems are intended to augment medical decision-making, not replace it. The human expertise of doctors remains paramount in the clinical decision-making process.

“The integration of AI is about enhancing the decision-making process for each patient, considering the multitude of factors and drawing upon extensive experience,” Callstrom explained.

The Mayo Clinic’s collaboration with Cerebras is anticipated to yield results that will be accessible via the Mayo Clinic Platform. This platform is a comprehensive data network already utilised by various healthcare systems such as Mercy in the U.S., the University Health Network in Canada, and other systems in Brazil and Israel.

While the pricing model for the AI technology developed through this partnership has not been finalised, Callstrom indicated that the Mayo Clinic intends to disclose further details about this venture during a presentation at JPMorgan Chase’s healthcare conference in San Francisco.

Andrew Feldman, CEO of Cerebras, described the deal as a multi-million-dollar agreement spanning several years, though he refrained from disclosing specific financial details. Cerebras, aspiring to compete with industry leaders like Nvidia, will provide both the necessary hardware and software development expertise as part of the agreement. This collaboration marks a significant step in integrating advanced AI capabilities into the healthcare sector, aiming to enhance patient care through technological innovation.